Artwork

Contenu fourni par David E. Williams. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par David E. Williams ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Overcoming antibiotic resistance. Interview with TAXIS CEO Greg Mario

29:18
 
Partager
 

Manage episode 428361253 series 2793637
Contenu fourni par David E. Williams. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par David E. Williams ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Greg Mario, CEO of TAXIS Pharmaceuticals shares his dynamic journey from a childhood of constant relocations to spearheading the fight against antibiotic-resistant infections. Greg opens up about his immigrant grandparents' profound influence and a transformative experience with a captivating professor at Trinity College that shifted his academic focus from mechanical engineering to chemistry. This pivotal change set the foundation for his career in the pharmaceutical industry, highlighting his adaptability and dedication to human health.
Discover the fascinating evolution of Evogen, a company initially centered on bio and chemical threat detection, which pivoted to tackle central nervous system diseases under Greg's leadership. We also explore the creation of as revolutionary blood-based epilepsy diagnostic test, as well as the pressing issue of antibiotic resistance.
Greg provides a historical perspective on antibiotics and underscores the urgent need for innovative antimicrobial treatments to combat the relentless rise of superbugs, emphasizing the resilience and adaptability required in the healthcare industry.
In the final section, we explore the relentless pursuit of funding in the biotech world through Greg's experiences with TAXIS Pharmaceuticals. Learn about the company's early days and the recent $2.7 million NIH grant for their promising efflux pump inhibitor, now on the brink of human trials.
As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.

Episodes through March 2025 were produced by Dafna Williams.

  continue reading

219 episodes

Artwork
iconPartager
 
Manage episode 428361253 series 2793637
Contenu fourni par David E. Williams. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par David E. Williams ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Greg Mario, CEO of TAXIS Pharmaceuticals shares his dynamic journey from a childhood of constant relocations to spearheading the fight against antibiotic-resistant infections. Greg opens up about his immigrant grandparents' profound influence and a transformative experience with a captivating professor at Trinity College that shifted his academic focus from mechanical engineering to chemistry. This pivotal change set the foundation for his career in the pharmaceutical industry, highlighting his adaptability and dedication to human health.
Discover the fascinating evolution of Evogen, a company initially centered on bio and chemical threat detection, which pivoted to tackle central nervous system diseases under Greg's leadership. We also explore the creation of as revolutionary blood-based epilepsy diagnostic test, as well as the pressing issue of antibiotic resistance.
Greg provides a historical perspective on antibiotics and underscores the urgent need for innovative antimicrobial treatments to combat the relentless rise of superbugs, emphasizing the resilience and adaptability required in the healthcare industry.
In the final section, we explore the relentless pursuit of funding in the biotech world through Greg's experiences with TAXIS Pharmaceuticals. Learn about the company's early days and the recent $2.7 million NIH grant for their promising efflux pump inhibitor, now on the brink of human trials.
As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.

Episodes through March 2025 were produced by Dafna Williams.

  continue reading

219 episodes

Alla avsnitt

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide

Écoutez cette émission pendant que vous explorez
Lire